Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 6;156(5):350-9.
doi: 10.7326/0003-4819-156-5-201203060-00007.

Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study

Ashwin N Ananthakrishnan  1 , Leslie M Higuchi, Edward S Huang, Hamed Khalili, James M Richter, Charles S Fuchs, Andrew T Chan
Affiliations

Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study

Ashwin N Ananthakrishnan et al. Ann Intern Med. .

Abstract

Background: Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are anti-inflammatory but have been linked in some studies to Crohn disease (CD) and ulcerative colitis (UC).

Objective: To assess the association between aspirin and NSAID use and incident CD and UC.

Design: Prospective cohort study.

Setting: Nurses' Health Study I.

Patients: 76,795 U.S. women who provided biennially updated data about aspirin and NSAID use.

Measurements: Incident CD and UC between 1990 and 2008 (outcome) and NSAID and aspirin use (exposure).

Results: 123 incident cases of CD and 117 cases of UC occurred over 18 years and 1,295,317 person-years of follow-up. Compared with nonusers, women who used NSAIDs at least 15 days per month seemed to have increased risk for both CD (absolute difference in age-adjusted incidence, 6 cases per 100,000 person-years [95% CI, 0 to 13]; multivariate hazard ratio, 1.59 [CI, 0.99 to 2.56]) and UC (absolute difference, 7 cases per 100,000 person-years [CI, 1 to 12]; multivariate hazard ratio, 1.87 [CI, 1.16 to 2.99]). Less frequent NSAID use was not clearly associated with risk for CD or UC, and there was no clear association between aspirin use and disease.

Limitations: Cohort participants were exclusively women, most of whom were white. Aspirin and NSAID use were self-reported.

Conclusion: Frequent use of NSAIDs but not aspirin seemed to be associated with increased absolute incidence of CD and UC. The findings have more mechanistic than clinical implications, because the absolute incidence of CD or UC associated with NSAIDs was low and the increase in risk for CD or UC associated with NSAIDs is unlikely to alter the balance of more common and clinically significant risks and benefits associated with these agents.

Primary funding source: American Gastroenterological Association, IBD Working Group, Broad Medical Research Program, and National Institutes of Health.

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts of Interest: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1760.

Figures

Figure 1
Figure 1. Study flow diagram
CD = Crohn disease; IBD = inflammatory bowel disease; UC = ulcerative colitis.
Figure 2
Figure 2. Timing of ascertainment of exposures and outcome
CD = Crohn disease; NSAID = nonsteroidal anti-inflammatory drug; UC = ulcerative colitis.
See this image and copyright information in PMC

References

    1. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005;294:914–23. - PMC - PubMed
    1. Huang ES, Strate LL, Ho WW, Lee SS, Chan AT. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med. 2011;124:426–33. - PMC - PubMed
    1. Musumba C, Pritchard DM, Pirmohamed M. Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment Pharmacol Ther. 2009;30:517–31. - PubMed
    1. Singh S, Graff LA, Bernstein CN. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol. 2009;104:1298–313. - PubMed
    1. Takeuchi K, Smale S, Premchand P, Maiden L, Sherwood R, Thjodleifsson B, et al. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:196–202. - PubMed

Publication types

Substances